LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global intraocular lens (IOLs) market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021.

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

ReportsnReports.com adds the global intraocular lens (IOL) market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly ...

NEW YORK, Oct. 12, 2017 /PRNewswire/ -- Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Intraocular Lens (IOL) - Medical Devices ...

Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...

The Global Intraocular Lens Market, valued at approximately US $3.9 billion in 2021, is projected to grow at a compound annual growth rate of around 5-6% over the next five years. This steady growth ...

Please provide your email address to receive an email when new articles are posted on . The implantation of intraocular lenses (IOLs) following removal of a cataractous crystalline lens is one of the ...

LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...